FABIFLU 200MG

Cipla Limited

Antiviral

Description
Shipping Options
Customer Reviews

1. Product Description

Brand Name: Fabiflu 200mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Pack Size: Typically 34 tablets/blister pack (for full course)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Active Ingredient: Favipiravir 200mg
Inactive Ingredients: Microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate, film coating agents

3. Therapeutic Uses

Approved Indication:

Treatment of mild to moderate COVID-19 in adults

Mechanism of Action:

RNA-dependent RNA polymerase inhibitor
Prevents viral replication of SARS-CoV-2

4. Recommended Dosage

Standard Treatment Protocol:

Day 1 (Loading Dose): 1800mg (9 tablets) twice daily
Days 2-10 (Maintenance): 800mg (4 tablets) twice daily
Total Duration: 10-14 days

Administration:

Take with or without food
Swallow whole with water
Maintain 12-hour intervals between doses

5. Contraindications

Pregnancy (Category X – high fetal risk)
Severe hepatic impairment
History of gout/hyperuricemia
Hypersensitivity to favipiravir

6. Side Effects

Common:

Nausea (12-15%)
Headache (5-8%)
Diarrhea (3-5%)
Elevated uric acid

Serious (require medical attention):

Severe hepatotoxicity
Allergic reactions
Neuropsychiatric symptoms

7. Storage Conditions

Store below 30°C
Protect from moisture
Keep in original packaging
Shelf life: 24 months

8. Special Precautions

Pregnancy test required before treatment
Effective contraception mandatory during and for 7 days post-treatment
Monitoring recommended:
- Liver function tests
- Uric acid levels
- Clinical response

9. Drug Interactions

Pyrazinamide: Increased uric acid
Repaglinide: Altered glucose control
Theophylline: May require dose adjustment

10. Manufacturer’s Note

For emergency use only in COVID-19
Not a substitute for vaccination
Use under medical supervision

Note: Treatment protocols may vary based on regional guidelines. Always consult a healthcare provider for personalized advice.

1. Product Description

Brand Name: Fabiflu 200mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Pack Size: Typically 34 tablets/blister pack (for full course)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Active Ingredient: Favipiravir 200mg
Inactive Ingredients: Microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate, film coating agents

3. Therapeutic Uses

Approved Indication:

Treatment of mild to moderate COVID-19 in adults

Mechanism of Action:

RNA-dependent RNA polymerase inhibitor
Prevents viral replication of SARS-CoV-2

4. Recommended Dosage

Standard Treatment Protocol:

Day 1 (Loading Dose): 1800mg (9 tablets) twice daily
Days 2-10 (Maintenance): 800mg (4 tablets) twice daily
Total Duration: 10-14 days

Administration:

Take with or without food
Swallow whole with water
Maintain 12-hour intervals between doses

5. Contraindications

Pregnancy (Category X – high fetal risk)
Severe hepatic impairment
History of gout/hyperuricemia
Hypersensitivity to favipiravir

6. Side Effects

Common:

Nausea (12-15%)
Headache (5-8%)
Diarrhea (3-5%)
Elevated uric acid

Serious (require medical attention):

Severe hepatotoxicity
Allergic reactions
Neuropsychiatric symptoms

7. Storage Conditions

Store below 30°C
Protect from moisture
Keep in original packaging
Shelf life: 24 months

8. Special Precautions

Pregnancy test required before treatment
Effective contraception mandatory during and for 7 days post-treatment
Monitoring recommended:
- Liver function tests
- Uric acid levels
- Clinical response

9. Drug Interactions

Pyrazinamide: Increased uric acid
Repaglinide: Altered glucose control
Theophylline: May require dose adjustment

10. Manufacturer’s Note

For emergency use only in COVID-19
Not a substitute for vaccination
Use under medical supervision

Note: Treatment protocols may vary based on regional guidelines. Always consult a healthcare provider for personalized advice.

Shipping Options –

We offer a variety of shipping options, including Express Mail Service (EMS), USPS, DHL, FedEx, TNT, UPS, Aramex, Air Cargo, and sea freight.

Terms and Conditions –

Bulk Orders: You are responsible for any local import duties and taxes in your country.

For Patients: When ordering prescription medicines for personal use, or for a friend or relative, a valid medical practitioner’s script or prescription is required.

Return and Refund Policy: Due to the nature of our products, we cannot accept returns or exchanges once a purchase is made. However, in the event of non-delivery, you are eligible for either a 100% refund or a reshipment of your order.

Description
Reviews (0)

1. Product Description

Brand Name: Fabiflu 200mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Pack Size: Typically 34 tablets/blister pack (for full course)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Active Ingredient: Favipiravir 200mg
Inactive Ingredients: Microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate, film coating agents

3. Therapeutic Uses

Approved Indication:

Treatment of mild to moderate COVID-19 in adults

Mechanism of Action:

RNA-dependent RNA polymerase inhibitor
Prevents viral replication of SARS-CoV-2

4. Recommended Dosage

Standard Treatment Protocol:

Day 1 (Loading Dose): 1800mg (9 tablets) twice daily
Days 2-10 (Maintenance): 800mg (4 tablets) twice daily
Total Duration: 10-14 days

Administration:

Take with or without food
Swallow whole with water
Maintain 12-hour intervals between doses

5. Contraindications

Pregnancy (Category X – high fetal risk)
Severe hepatic impairment
History of gout/hyperuricemia
Hypersensitivity to favipiravir

6. Side Effects

Common:

Nausea (12-15%)
Headache (5-8%)
Diarrhea (3-5%)
Elevated uric acid

Serious (require medical attention):

Severe hepatotoxicity
Allergic reactions
Neuropsychiatric symptoms

7. Storage Conditions

Store below 30°C
Protect from moisture
Keep in original packaging
Shelf life: 24 months

8. Special Precautions

Pregnancy test required before treatment
Effective contraception mandatory during and for 7 days post-treatment
Monitoring recommended:
- Liver function tests
- Uric acid levels
- Clinical response

9. Drug Interactions

Pyrazinamide: Increased uric acid
Repaglinide: Altered glucose control
Theophylline: May require dose adjustment

10. Manufacturer’s Note

For emergency use only in COVID-19
Not a substitute for vaccination
Use under medical supervision

Note: Treatment protocols may vary based on regional guidelines. Always consult a healthcare provider for personalized advice.

Reviews

There are no reviews yet.

Be the first to review “FABIFLU 200MG”

Description
Reviews (0)

1. Product Description

Brand Name: Fabiflu 200mg
Generic Name: Favipiravir
Manufacturer: Glenmark Pharmaceuticals (India)
Dosage Form: Film-coated tablets
Pack Size: Typically 34 tablets/blister pack (for full course)
Approval Status: Emergency use authorization for COVID-19 in India

2. Composition

Active Ingredient: Favipiravir 200mg
Inactive Ingredients: Microcrystalline cellulose, povidone K30, croscarmellose sodium, magnesium stearate, film coating agents

3. Therapeutic Uses

Approved Indication:

Treatment of mild to moderate COVID-19 in adults

Mechanism of Action:

RNA-dependent RNA polymerase inhibitor
Prevents viral replication of SARS-CoV-2

4. Recommended Dosage

Standard Treatment Protocol:

Day 1 (Loading Dose): 1800mg (9 tablets) twice daily
Days 2-10 (Maintenance): 800mg (4 tablets) twice daily
Total Duration: 10-14 days

Administration:

Take with or without food
Swallow whole with water
Maintain 12-hour intervals between doses

5. Contraindications

Pregnancy (Category X – high fetal risk)
Severe hepatic impairment
History of gout/hyperuricemia
Hypersensitivity to favipiravir

6. Side Effects

Common:

Nausea (12-15%)
Headache (5-8%)
Diarrhea (3-5%)
Elevated uric acid

Serious (require medical attention):

Severe hepatotoxicity
Allergic reactions
Neuropsychiatric symptoms

7. Storage Conditions

Store below 30°C
Protect from moisture
Keep in original packaging
Shelf life: 24 months

8. Special Precautions

Pregnancy test required before treatment
Effective contraception mandatory during and for 7 days post-treatment
Monitoring recommended:
- Liver function tests
- Uric acid levels
- Clinical response

9. Drug Interactions

Pyrazinamide: Increased uric acid
Repaglinide: Altered glucose control
Theophylline: May require dose adjustment

10. Manufacturer’s Note

For emergency use only in COVID-19
Not a substitute for vaccination
Use under medical supervision

Note: Treatment protocols may vary based on regional guidelines. Always consult a healthcare provider for personalized advice.

Reviews

There are no reviews yet.

Be the first to review “FABIFLU 200MG”

Medical Disclaimer

Anteka Pharmacy primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Anteka Pharmacy. Our mission is to support, not replace, the doctor-patient relationship.